Publication | Closed Access
Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts
463
Citations
24
References
2007
Year
Both in vivo costimulation and repeated administration enhance eradication of systemic tumor by genetically targeted T cells. The finding that modifications in CAR design as well as T-cell dosing allowed for the complete eradication of systemic disease affects the design of clinical trials using this treatment strategy.
| Year | Citations | |
|---|---|---|
2002 | 997 | |
2004 | 806 | |
2003 | 655 | |
1998 | 532 | |
2005 | 484 | |
2006 | 481 | |
2004 | 450 | |
2002 | 444 | |
Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Isabelle Rivière, Katja Brose, Richard Mulligan Proceedings of the National Academy of Sciences Human Adenosine DeaminaseCell TherapyImmunologyPathologyRetroviral Vector Design | 1995 | 370 |
2001 | 352 |
Page 1
Page 1